|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-3-28
|
|
pubmed:abstractText |
Although combinations of different antiretroviral drugs are increasingly used by pregnant HIV-1-infected women, few human data are available to evaluate in utero protease inhibitors (PI) exposure. The aim of this study was to assess the extent of transplacental passage of PI at delivery.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
12
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
889-93
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11919490-Chromatography, High Pressure Liquid,
pubmed-meshheading:11919490-Cohort Studies,
pubmed-meshheading:11919490-Delivery, Obstetric,
pubmed-meshheading:11919490-Female,
pubmed-meshheading:11919490-Fetal Blood,
pubmed-meshheading:11919490-HIV Infections,
pubmed-meshheading:11919490-HIV Protease Inhibitors,
pubmed-meshheading:11919490-Humans,
pubmed-meshheading:11919490-Maternal-Fetal Exchange,
pubmed-meshheading:11919490-Pregnancy,
pubmed-meshheading:11919490-Viral Load
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Transplacental passage of protease inhibitors at delivery.
|
|
pubmed:affiliation |
Division of Clinical Pharmacology, University Hospital of Lausanne, Lausanne, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
